Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probenecid addition to Penicillin-V in healthy volunteers
NCT05082909Phase 2Completed
- Sponsor
- Imperial College London
- Start
- Dec 2021
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of probenecid in bacterial infection, sponsored by Imperial College London. Started Dec 2021; status: completed.
02
Drugs
probenecid
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT05082909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05082909.